European Archives - Page 94 of 1112 - European Medical Journal

Nasal Microbiota Transplants: A New Frontier in Chronic Rhinosinusitis

Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections.

Microsoft and Cerebras to Revolutionise AI in Medical Imaging

Mayo Clinic partners with Microsoft and Cerebras to harness AI for faster, more precise diagnostics and personalised treatments.

Repurposing COVID-19 Vaccines for Effective Cancer Therapy

A groundbreaking study investigated repurposing the COVID-19 mRNA vaccine for cancer treatment.

Total Body Photography with Body Mapping

In this video, Robyn Siperstein emphasises the importance of high-quality total body photography in modern cosmetic and medical…

J&J’s Martin Price on World Cancer Day 2025 – Part 1

A World Cancer Day edition of the podcast, with Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, J&J.

New Model Predicts Hepatocellular Carcinoma Risk in Patients with Noncirrhotic Hepatitis B

A new model predicts HCC risk in noncirrhotic CHB patients, focusing on HBV DNA levels and other key factors.

New Approach to Treating Depression and Anxiety: Virtual Reality Meditation

Immersive virtual reality meditation significantly reduces depression and anxiety in hospital inpatients, enhancing emotional regulation and well-being.

New Study Links Rheumatoid Arthritis to Increased Prostate Cancer Risk

A new study has found a causal link between rheumatoid arthritis and an increased risk of prostate cancer, highlighting the role of chronic inflammation in cancer development.

Low Oxygen Levels Threaten Male Fertility and Future Generations

New research highlights how sleep apnoea, varicocele, and hypoxia impact male fertility, with potential intergenerational consequences.

Family History of Frequent Polyps Linked to Increased Risk of Colorectal Cancer

Frequent polyp diagnoses in relatives significantly raise the risk of colorectal cancer, particularly for early-onset cases.